Search - tctmd.com

Displaying 301 - 320 of 1388

Sort: Relevancy | Date

Presentation TCT 2016

TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE)

Presenter: Zahid Amin, Jacqueline Saw, David Hildick-Smith

October 31, 2016

Presentation TCT 2016

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Blase A. Carabello

October 31, 2016

Presentation TCT 2016

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

Presenter: Joseph A. Hill, Steven P. Marso, Adam B. Greenbaum

October 31, 2016

Presentation TCT 2016

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

Presenter: Spencer B. King III, Jagat Narula, Henrique B. Ribeiro

October 31, 2016

Presentation TCT 2016

TCT 43: Outcomes After Paravalvular Leak Closure: Percutaneous Versus Surgical Approaches

Presenter: Stephan Baldus, Allan Schwartz, John Wells

October 31, 2016

Presentation TCT 2016

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

Presenter: Lutz Buellesfeld, Raj Makkar, Ian T. Meredith

October 31, 2016

Presentation TCT 2016

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

Presenter: Charles J. Davidson, Michael J. Reardon, James B. Hermiller Jr.

October 31, 2016

Presentation TCT 2016

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy

Presenter: Zahid Amin, Jacqueline Saw, Jens Erik Nielsen-Kudsk

October 31, 2016

Presentation TCT 2016

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

Presenter: Michael Argenziano, Alec S. Vahanian, Daniel Burkhoff

October 31, 2016

Presentation TCT 2016

TCT 42: Transcatheter Echo Guided Mitral Valve Repair With Neochord Implantation for Posterior Leaflet Disease: Results From Neochord Independent International Registry

Presenter: Stephan Baldus, Allan Schwartz, Andrea Colli

October 31, 2016

Presentation TCT 2016

TCT 38: Paravalvular Regurgitation Regression and Impact on One-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Transcatheter Valve

Presenter: Lutz Buellesfeld, Raj Makkar, Philippe Pibarot

October 31, 2016

Title Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presentation TCT 2016

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

Presenter: Charles J. Davidson, Michael J. Reardon, Suzanne Baron

October 31, 2016

Presentation TCT 2016

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Presenter: Zahid Amin, Jacqueline Saw, Vivek Y. Reddy

October 31, 2016

Presentation TCT 2016

Rationale for and Design of GALILEO

Presenter: Michael Argenziano, Alec S. Vahanian, Paul Sorajja

October 31, 2016

Presentation TCT 2016

EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTO Intervention after Primary PCI in Patients with STEMI

Presenter: Joseph A. Hill, Steven P. Marso, Jose P.S. Henriques

October 31, 2016

Presentation TCT 2016

TCT 41: Up to Two Years Follow-up Results of Mitral Valve Transcatheter Annuloplasty System for Mitral Reconstruction Multicenter Trial

Presenter: Stephan Baldus, Allan Schwartz, Karl-Heinz Kuck

October 31, 2016

Presentation TCT 2016

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

Presenter: Lutz Buellesfeld, Raj Makkar, Jeffrey J. Popma

October 31, 2016

Presentation TCT 2016

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

Presenter: Charles J. Davidson, Michael J. Reardon, James Harvey

October 31, 2016

Presentation TCT 2016

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials

Presenter: Zahid Amin, Jacqueline Saw, Luis Nombela-Franco

October 31, 2016

Presentation TCT 2016

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara

October 31, 2016

Advertisement

TCT 28: Occlutech Percutaneous PFO Closure: Safety and Efficacy Registry (OPPOSE)

Rationale for and Design of COAPT: What I Expect the Findings to Be But What Wont Surprise Me!

A Multicenter, Prospective Registry of Transcaval access and closure for transcatheter aortic valve replacement

TOPAS-TAVI: A Prospective, Multicenter Registry Evaluating Transcatheter Aortic Valve Implantation in Patients with Low-Flow, Low-Gradient Aortic Stenosis

TCT 43: Outcomes After Paravalvular Leak Closure: Percutaneous Versus Surgical Approaches

TCT 39: Three-Year Outcomes With the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Replacement Valve in 120 High-Risk Surgical Patients With Severe Aortic Stenosis: Results From the REPRISE II CE-Mark Study

TCT 35: Predictors of Early Aortic Valve Rehospitalization Following Self-Expanding Transcatheter Aortic Valve Replacement: Results From the CoreValve US Trial Program

TCT 27: Transcatheter Left Atrial Appendage Occlusion Using Aspirin Alone for Post-Implant Antithrombotic Therapy

Rationale for and Design of TAVR UNLOAD: What I Expect the Findings to Be But What Wont Surprise Me!

TCT 42: Transcatheter Echo Guided Mitral Valve Repair With Neochord Implantation for Posterior Leaflet Disease: Results From Neochord Independent International Registry

TCT 38: Paravalvular Regurgitation Regression and Impact on One-Year Outcomes After Transcatheter Aortic Valve Replacement With the SAPIEN 3 Transcatheter Valve

TCT 34: Effect of Sapien-3 Transcatheter Valve Implant on Health Status in Patients with Severe Aortic Stenosis at Intermediate Surgical Risk: Results from the PARTNER S3i Trial

TCT 26: Long-term Event Rates for Left Atrial Appendage Closure With WATCHMAN: PROTECT AF Five-Year and PREVAIL Three-Year Follow-up

Rationale for and Design of GALILEO

EXPLORE: Left Ventricular Function Recovery from a Prospective, Randomized Trial of CTO Intervention after Primary PCI in Patients with STEMI

TCT 41: Up to Two Years Follow-up Results of Mitral Valve Transcatheter Annuloplasty System for Mitral Reconstruction Multicenter Trial

TCT 37: Transcatheter Aortic Valve Replacement With a Repositionable Self-Expanding Bioprosthesis in Patients With Severe Aortic Stenosis at High Risk for Surgery: One-Year Results From the Evolut R US Pivotal Study

TCT 33: Predictors of Hospital Readmissions After Transcatheter Aortic Valve Replacement

TCT 25: Efficacy and Safety of Left Atrial Appendage Closure vs Medical Treatment in Atrial Fibrillation: A Network Meta-Analysis From Randomized Trials

Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content